午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Inhibitoren

Click on the specific product, view the latest information of the products, serving information
Structure Chemical Name CAS MF
CAY10603 CAY10603 1045792-66-2 C22H30N4O6
Droxinostat Droxinostat 99873-43-5 C11H14ClNO3
TMP269 TMP269 1314890-29-3 C25H21F3N4O3S
ITF2357 ITF2357 732302-99-7 C24H30ClN3O5
Nexturastat A Nexturastat A 1403783-31-2 C19H23N3O3
6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one 6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one 1286739-19-2 C29H28ClN7OS
IPA-3 IPA-3 42521-82-4 C20H14O2S2
Vinflunine Tartrate Vinflunine Tartrate 1201898-17-0 C49H60F2N4O14
CW069 CW069 1594094-64-0 C23H21IN2O3
VER-50589 VER-50589 747413-08-7 C19H17ClN2O5
XL888 XL888 1149705-71-4 C29H37N5O3
NVP-HSP990(HSP990) NVP-HSP990(HSP990) 934343-74-5 C20H18FN5O2
ENMD-2076 (Tartrate) ENMD-2076 (Tartrate) 1291074-87-7 C21H25N7.x(C4H6O6)
G-749 G-749 1457983-28-6 C25H25BrN6O2
Dovitinib Dilactic acid (TKI258 Dilactic acid) Dovitinib Dilactic acid (TKI258 Dilactic acid) 852433-84-2 C24H27FN6O4
3-(2,4-Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone 3-(2,4-Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone 338967-87-6 C15H10Cl2N2O2S
A 205804 A 205804 251992-66-2 C15H12N2OS2
Entospletinib (GS-9973) Entospletinib (GS-9973) 1229208-44-9 C23H21N7O
Tirbanibulin Tirbanibulin 897016-82-9 C26H29N3O3
TAK875 TAK875 1374598-80-7 C58H66O15S2
CNX-774 CNX-774 1202759-32-7 C26H22FN7O3
AZD 9668 AZD 9668 848141-11-7 C25H22F3N5O4S
N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA 792173-99-0 C17H13N5O2
CEP-32496 (free base) CEP-32496 (free base) 1188910-76-0 C24H22F3N5O5
Teneligliptin Hydrobromide Teneligliptin Hydrobromide 906093-29-6 C22H31BrN6OS
KU 0060648 KU 0060648 881375-00-4 C33H34N4O4S
AT-101 AT-101 866541-93-7 C32H34O10
BAY 87-2243 BAY 87-2243 1227158-85-1 C26H26F3N7O2
GW 842166X GW 842166X 666260-75-9 C18H17Cl2F3N4O2
Losmapimod (GW856553X) Losmapimod (GW856553X) 585543-15-3 C22H26FN3O2
4-[[4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone 4-[[4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone 890090-75-2 C30H30Cl2N4O4
2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one 1234480-50-2 C26H30N6O3
(R)-2-((R)-6,7-diMethoxy-1-(4-(trifluoroMethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-Methyl-2-phenylacetaMide (R)-2-((R)-6,7-diMethoxy-1-(4-(trifluoroMethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-Methyl-2-phenylacetaMide 913358-93-7 C29H31F3N2O3
AZ20 AZ20 1233339-22-4 C21H24N4O3S
GDC-0152 GDC-0152 873652-48-3 C25H34N6O3S
RG-7388 RG-7388 1229705-06-9 C31H29Cl2F2N3O4
Nutlin-3b Nutlin-3b 675576-97-3 C30H30Cl2N4O4
VE 822 VE 822 1232416-25-9 C24H25N5O3S
Encorafenib (LGX818) Encorafenib (LGX818) 1269440-17-6 C22H27ClFN7O4S
Refametinib Refametinib 923032-37-5 C19H20F3IN2O5S
NSC319726 NSC319726 71555-25-4 C11H14N4S
BAM7 BAM7 331244-89-4 C21H19N5O2S
GSK2656157 GSK2656157 1337532-29-2 C23H21FN6O
4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide 4-(4-Methyl-1-piperazinyl)-7-nitrobenzofurazane 3-oxide 58131-57-0 C11H13N5O4
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine 865362-74-9 C18H13N7
7-Methyl-5-[(3-piperazin-1-ylMethyl)-1,2,4-oxadiazol-5-yl-]-2-[4-(trifluoroMethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one Methanesulphonate 7-Methyl-5-[(3-piperazin-1-ylMethyl)-1,2,4-oxadiazol-5-yl-]-2-[4-(trifluoroMethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one Methanesulphonate 802904-66-1 C19H17ClN2O3S
JNK-IN-8 JNK-IN-8 1410880-22-6 C29H29N7O2
FGFR inhibitor FGFR inhibitor 848318-25-2 C18H15N2NaO4
FLI-06 FLI-06 313967-18-9 C25H30N2O5
BMH21 BMH21 896705-16-1 C21H20N4O2
MMP-2/MMP-9 INHIBITOR IV MMP-2/MMP-9 INHIBITOR IV 292605-14-2 C15H14O3S2
Voreloxin Voreloxin 175414-77-4 C18H19N5O4S
PF 543 PF 543 1415562-82-1 C27H31NO4S
Z-PHE-DL-ALA-FLUOROMETHYLKETONE Z-PHE-DL-ALA-FLUOROMETHYLKETONE 197855-65-5 C21H23FN2O4
CGS 21680A CGS 21680A 124431-80-7 C23H30ClN7O6
LDN-193189 HCl LDN-193189 HCl 1062368-62-0 C25H23ClN6
DBeQ DBeQ 177355-84-9 C22H20N4
GNE 7915 GNE 7915 1351761-44-8 C19H21F4N5O3
P 22077 P 22077 1247819-59-5 C12H7F2NO3S2
Cabotegravir (GSK744, GSK1265744) Cabotegravir (GSK744, GSK1265744) 1051375-10-0 C19H17F2N3O5
Verdinexor (KPT-335) Verdinexor (KPT-335) 1392136-43-4 C18H12F6N6O
6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline 6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline 1139889-93-2 C17H14F2N2
Nodinitib-1 Nodinitib-1 799264-47-4 C14H13N3O2S
IKK Inhibitor III, BMS-345541 IKK Inhibitor III, BMS-345541 445430-58-0 C14H17N5
K 02288 K 02288 1431985-92-0 C20H20N2O4
Selinexor Selinexor 1393477-72-9 C17H11F6N7O
ML-323 ML-323 1572414-83-5 C23H24N6
LDN212854 LDN212854 1432597-26-6 C25H22N6
WS3 WS3 1421227-52-2 C28H30F3N7O3
Raf265 derivative Raf265 derivative 1942849-27-5 C23H14F6N6O
WIKI4 WIKI4 838818-26-1 C29H23N5O3S
4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline 1206711-16-1 C24H20N4O
BI-97C1 BI-97C1 1228108-65-3 C42H40N2O8
MK-2048 MK-2048 869901-69-9 C21H21ClFN5O4
AHAS inhibitor AHAS inhibitor 219793-45-0 C19H12ClNO6S
HO-3867 HO-3867 1172133-28-6 C28H30F2N2O2
CEP 33779 CEP 33779 1257704-57-6 C24H26N6O2S
Dolutegravir sodium Dolutegravir sodium 1051375-19-9 C20H20F2N3NaO5
GNE-0877 GNE-0877 1374828-69-9 C14H16F3N7
PYR 41 PYR 41 418805-02-4 C17H13N3O7
pf-5274857 pf-5274857 1373615-35-0 C20H25ClN4O3S
ML 133 Hydrochloride ML 133 Hydrochloride 1222781-70-5 C19H20ClNO
ZM 39923 HCl ZM 39923 HCl 1021868-92-7 C23H26ClNO
NSC697923 NSC697923 343351-67-7 C11H9NO5S
BV6 BV6 1001600-56-1 C70H96N10O8
BAF-312(SiponiMod) BAF-312(SiponiMod) 1230487-00-9 C29H35F3N2O3
Ki16198 Ki16198 355025-13-7 C24H25ClN2O5S
LGK-974 LGK-974 1243244-14-5 C23H20N6O
(Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3- (Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3- 1421919-75-6 C16H10F8N4O
GNE-9605 GNE-9605 1536200-31-3 C17H20ClF4N7O
SD-208 SD-208 627536-09-8 C17H10ClFN6
S-Ruxolitinib (INCB018424) S-Ruxolitinib (INCB018424) 941685-37-6 C17H18N6
5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a] 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a] 1062368-49-3 C22H16N4O
WS6 WS6 1421227-53-3 C29H31F3N6O3
LRRK2-kinase inhibitor LRRK2-kinase inhibitor 1285515-21-0 C24H18FN3O2
IWP L6 IWP L6 1427782-89-5 C25H20N4O2S2
IKK 16 IKK 16 873225-46-8 C28H29N5OS
b-AP15 b-AP15 1009817-63-3 C22H17N3O6
LDN-214117 LDN-214117 1627503-67-6 C25H29N3O3
SH-4-54 SH-4-54 1456632-40-8 C29H27F5N2O5S
Website-Startseite | Mitglied Firmen | Werbung | ueber uns
Copyright © 2016 ChemicalBook All rights reserved.